[Clinical significance of Serratia isolation from sputa of patients with respiratory diseases (author's transl)].

[1]  T. Merigan,et al.  Patient factors contributing to the emergence of gentamicin-resistant Serratia marcescens. , 1979, The American journal of medicine.

[2]  S. Webb,et al.  Outbreak of Serratia Marcescens Associated with the Flexible Fiberbronchoscope , 1975 .

[3]  M. Grieco,et al.  Characteristics of Serratia marcescens pneumonia. , 1973, Archives of internal medicine.

[4]  F. Felton,et al.  Contamination of ultrasonic nebulization equipment with gram negative bacteria. , 1971, Archives of internal medicine.

[5]  W. J. Martin,et al.  Serratia marcescens: Biochemical Characteristics, Antibiotic Susceptibility Patterns, and Clinical Significance , 1970 .

[6]  C. Sanders,et al.  Serratia marcescens infections from inhalation therapy medications: nosocomial outbreak. , 1970, Annals of internal medicine.

[7]  H. Muchmore,et al.  A hospital outbreak of Serratia marcescens associated with ultrasonic nebulizers. , 1968, Annals of internal medicine.

[8]  E. Clayton,et al.  Nonpigmented Serratia marcescens. , 1966, JAMA.

[9]  L. Lancaster.  Role of Serratia species in urinary tract infections. , 1962, Archives of internal medicine.

[10]  B. Davis,et al.  The Occurrence of Serratia marcescens in Nosocomial Infections. , 1962 .

[11]  J. Papapanagiotou,et al.  ISOLATION OF CHROMOBACTERIUM PRODIGIOSUM FROM EMPYEMA , 1959, Journal of clinical pathology.

[12]  W. Robinson,et al.  Pseudohaemoptysis due to Chromobacterium prodigiosum. , 1957, Lancet.

[13]  H. Woodward,et al.  A CASE OF INFECTION IN MAN BY THE BACTERIUM PRODIGIOSUM. , 1913 .